We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Extended Range HRP Microwell Substrate Launched

By LabMedica International staff writers
Posted on 18 Jul 2012
AACC 2012: An extended range horseradish peroxidase (HRP) microwell substrate was launched at the American Association for Clinical Chemistry (AACC) show in Los Angeles (CA, USA), taking place from July 15-19, 2012.

A product of SurModics (Eden Prairie, MN, USA), the BioFX TMB extended range HRP microwell substrate (TMBX), when used in a quantitative assay, increases the assay's upper limit of quantization and maintains the detection limits and analytical sensitivity achieved with other TMB substrates. More...
TMBX also improves the reproducibility of the assay through lower backgrounds and better control of assay timing.

TMBX is SurModic's slowest kinetic option of TMB substrates for extended dynamic range and improved reproducibility within. It is a colorimetric substrate for HRP detection in microwell applications. TMBX is a one-component substrate that requires no preparation prior to use.

The right substrate can make a substantial contribution to the overall sensitivity of an assay. SurModics offers a variety of colorimetric TMB substrates and complementary novel stop solutions, available in both bulk and custom dispenses.

SurModics' offers new surface modification technologies and in vitro diagnostic chemical components. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities, and components for in vitro diagnostic tests and microarrays.

Related Links:

SurModics




Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Staining System
RAL DIFF-QUIK
New
PSA Assay
CanAg PSA EIA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.